Intrinsic Value

The intrinsic value of INOVIQ Ltd (EGQ0) under the Base Case is 0.0424 EUR per share. Compared with the current market price of 0.0725 EUR, the stock appears Overvalued by 42% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

EGQ0 Intrinsic Value
€0.0424
Overvaluation 42%
Intrinsic Value
Price €0.0725
Alert me when EGQ0 is below its intrinsic value
Today €0.0339 · 53.3% below the current price

EGQ0 is cheaper than usual. Still overvalued, but less so than on 96% of days in the past 5 years.

Alternatives to EGQ0

Fundamental Analysis

What INOVIQ Does

Health Care

INOVIQ Ltd is an Australian life sciences company focused on cancer diagnostics and exosome-based tools. Its main work is to develop blood tests and related technologies that help detect cancer earlier, with a particular emphasis on ovarian and breast cancer. The company also works on exosome science, which uses tiny particles released by cells as a source of diagnostic and research information.

Headquarters
Australia AU
Employees
15
IPO date
Apr 18, 1991
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
INOVIQ Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one EGQ0 stock?

The intrinsic value for INOVIQ Ltd (EGQ0) under the Base Case is 0.0424 EUR.

Is EGQ0 stock undervalued or overvalued?

Compared with the current market price of 0.0725 EUR, the stock appears Overvalued by 42% .

Back to Top